Evidence map›Paper›PMID 32411386›Full record

ArticleNPJ genomic medicine2020

Clinical utility of 24-h rapid trio-exome sequencing for critically ill infants.

Huijun Wang, Yanyan Qian, Yulan Lu, Qian Qin, Guoping Lu, Guoqiang Cheng, Ping Zhang, Lin Yang, Bingbing Wu, Wenhao Zhou

Open access · goldAbstract read
In one paragraph

Article in NPJ genomic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Rapid genomic sequencing in the NICU: Who to test and why.European journal of human genetics : EJHG · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. The Role of Genome Sequencing in Neonatal Intensive Care Units.Annual review of genomics and human genetics · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Huijun Wang *1Center for Molecular Medicine, Children's Hospital of Fudan University, 201102 Shanghai, China.ORCID 0000-0002-9992-6457
Yanyan Qian *1Center for Molecular Medicine, Children's Hospital of Fudan University, 201102 Shanghai, China.
Yulan Lu1Center for Molecular Medicine, Children's Hospital of Fudan University, 201102 Shanghai, China.ORCID 0000-0003-4941-5736
Qian Qin1Center for Molecular Medicine, Children's Hospital of Fudan University, 201102 Shanghai, China.
Guoping Lu2Pediatric intensive care unit, Children's Hospital of Fudan University, 201102 Shanghai, China.
Guoqiang Cheng3Department of Neonates, Key Laboratory of Neonatal Diseases, Ministry of Health, Children's Hospital of Fudan University, 201102 Shanghai, China.
Ping Zhang1Center for Molecular Medicine, Children's Hospital of Fudan University, 201102 Shanghai, China.
Lin Yang1Center for Molecular Medicine, Children's Hospital of Fudan University, 201102 Shanghai, China.
Bingbing Wu1Center for Molecular Medicine, Children's Hospital of Fudan University, 201102 Shanghai, China.
Wenhao Zhou1Center for Molecular Medicine, Children's Hospital of Fudan University, 201102 Shanghai, China.ORCID 0000-0001-8956-7238
Children's Hospital of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic diseases are a leading cause of death in infants in the intensive care setting; therefore, rapid and accurate genetic diagnosis is desired. To validate 24-h trio-exome sequencing (TES), samples from probands and their parents were processed by the AmpliSeq /Ion S5XL platform in a hospital clinical laboratory. Infants from the intensive care unit (ICU) suspected of having a genetic disease were enrolled. Regular and 24-h TES using the Agilent SureSelect capture kit/Illumina platform were performed on all samples in parallel. Of 33 enrolled infants, 23 received positive results with rapid TES, and an additional two diagnoses were achieved with regular TES. Among the 23 diagnosed patients, 10 experienced changes in medical management, such as hematopoietic stem cell transplant. Ten diagnosed cases were discharged prior to receiving the regular TES results; six received timely symptom control, and four withdrew medical support. Rapid TES enabled faster time to diagnosis, which resulted in an overall decrease in length of hospital stay. The 24-h TES can serve as a rapid response tool for patients with suspected monogenic disorders and can guide clinical decision-making in urgent cases.

Indexed as

Genetic testingMolecular medicine

Identifiers

PMID32411386
PMCPMC7200743
OpenAlexW3021115440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.